Thermo Fisher Scientific | TMO - Selling And Administration Expenses


Thermo Fisher Scientific reported $1.86B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Agilent USD 475M 10M Jun/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Bio Techne USD 67.42M 41.91M Jun/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Boston Scientific USD 1.68B 120M Sep/2026
Bruker USD 226.5M 12.4M Sep/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 363M 1000K Sep/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
General Electric Aerospace USD 1.09B 40M Sep/2026
Henry Schein USD 819M 12M Sep/2026
Illumina USD 281M 8M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Laboratory Of America USD 611.4M 34.2M Sep/2026
Medtronic 3.2B 141M Jun/2026
Mettler Toledo International USD 267.16M 3.82M Sep/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Olympus JPY 126.1B 1.06B Sep/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quest Diagnostics USD 523M 6M Sep/2026
Repligen USD 83.59M 6.97M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Stryker USD 2.12B 32M Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Veracyte USD 57.95M 2.25M Sep/2026
Waters USD 398M 7M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026